Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Category 1 Bulk substance the FDA considers eligible for use in compounding pending final rulemaking Generally permitted Category 2 Bulk substance the FDA has significant safety, identity, or quality concerns about Not permitted during review Category 3 Substance requiring further evaluation Case-by-case Critically, Category 1 status is not FDA approval
Osteoarthritis: By promoting cartilage metabolism and reducing inflammatory cytokines, peptides offer a regenerative alternative to repeated corticosteroid injections that can accelerate cartilage degradation
Instead, use different peptides for different areas or rotate between them
[7] By inhibiting Caspase-3, Epithalon might contribute to cellular longevity and reduced apoptosis, which may complement its regenerative potential, yet this hypothesis demands more comprehensive research for validation
US$ 29.63
US$ 20.28
US$ 24.55
US$ 25.02
